Tuberculosis in renal transplant recipients on various immunosuppressive regimens


Creative Commons License

ATASEVER A. , BACAKOGLU F. , TOZ H. , BASOGLU O., DUMAN S. , BASAK K., ...Daha Fazla

NEPHROLOGY DIALYSIS TRANSPLANTATION, cilt.20, ss.797-802, 2005 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 20 Konu: 4
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1093/ndt/gfh691
  • Dergi Adı: NEPHROLOGY DIALYSIS TRANSPLANTATION
  • Sayfa Sayıları: ss.797-802

Özet

Background. Mycophenolate mofetil (MMF) and tacrolimus (TAC) are more potent than conventional immunosuppressive drugs, i.e. azathioprine, cyclosporin and prednisolone, and may be associated with an increase in the incidence of infections in the post-transplantation (post-tx) period. The aim of this study was to determine if the use of either or both of MMF and TAC for immunosuppression in renal transplant recipients increases the prevalence or modifies the clinical presentation of tuberculosis (TB), when compared with conventional therapy.